Concepts (167)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 5 | 2025 | 874 | 1.800 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2024 | 133 | 1.450 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 167 | 1.410 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 6 | 2022 | 285 | 1.290 |
Why?
|
| Lipogenesis | 3 | 2022 | 29 | 1.010 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 4 | 2022 | 17 | 0.920 |
Why?
|
| Energy Metabolism | 2 | 2025 | 215 | 0.890 |
Why?
|
| Membrane Proteins | 3 | 2018 | 485 | 0.860 |
Why?
|
| Herpesvirus 1, Cercopithecine | 1 | 2022 | 1 | 0.750 |
Why?
|
| Hepatitis B, Chronic | 1 | 2022 | 6 | 0.740 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2022 | 25 | 0.730 |
Why?
|
| Antirheumatic Agents | 1 | 2022 | 57 | 0.710 |
Why?
|
| Immunotherapy | 1 | 2022 | 163 | 0.640 |
Why?
|
| Lipid Metabolism | 3 | 2018 | 150 | 0.560 |
Why?
|
| Cell Culture Techniques | 1 | 2016 | 117 | 0.480 |
Why?
|
| Antineoplastic Agents | 2 | 2018 | 686 | 0.460 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 2022 | 38 | 0.430 |
Why?
|
| Humans | 19 | 2025 | 28851 | 0.410 |
Why?
|
| p21-Activated Kinases | 2 | 2009 | 7 | 0.380 |
Why?
|
| Glioblastoma | 3 | 2020 | 109 | 0.370 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 249 | 0.370 |
Why?
|
| Animals | 14 | 2025 | 10684 | 0.360 |
Why?
|
| Nephrons | 2 | 2022 | 8 | 0.310 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2009 | 7 | 0.300 |
Why?
|
| Cell Movement | 2 | 2020 | 376 | 0.290 |
Why?
|
| Endoplasmic Reticulum | 3 | 2018 | 80 | 0.290 |
Why?
|
| MAP Kinase Signaling System | 1 | 2009 | 95 | 0.280 |
Why?
|
| Glucose | 2 | 2022 | 209 | 0.270 |
Why?
|
| Carrier Proteins | 1 | 2009 | 255 | 0.260 |
Why?
|
| Golgi Apparatus | 2 | 2016 | 26 | 0.250 |
Why?
|
| Glycosylation | 2 | 2016 | 70 | 0.250 |
Why?
|
| Mice, Nude | 5 | 2020 | 332 | 0.240 |
Why?
|
| Transcription Factors | 3 | 2016 | 523 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 44 | 0.240 |
Why?
|
| Hematopoiesis | 1 | 2025 | 25 | 0.230 |
Why?
|
| Leukemia | 1 | 2025 | 30 | 0.220 |
Why?
|
| Polyamines | 1 | 2024 | 13 | 0.220 |
Why?
|
| Transplantation, Heterologous | 3 | 2022 | 60 | 0.210 |
Why?
|
| Protein Binding | 4 | 2016 | 667 | 0.210 |
Why?
|
| Insulin | 2 | 2022 | 325 | 0.210 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2022 | 2 | 0.200 |
Why?
|
| Islets of Langerhans | 1 | 2022 | 9 | 0.200 |
Why?
|
| Organ Transplantation | 1 | 2022 | 13 | 0.190 |
Why?
|
| Sterols | 1 | 2022 | 3 | 0.190 |
Why?
|
| Graft Rejection | 1 | 2022 | 34 | 0.190 |
Why?
|
| Ammonia | 1 | 2022 | 18 | 0.190 |
Why?
|
| Virus Activation | 1 | 2022 | 9 | 0.190 |
Why?
|
| Glutamine | 1 | 2022 | 32 | 0.190 |
Why?
|
| Hepatitis B virus | 1 | 2022 | 16 | 0.180 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2022 | 98 | 0.180 |
Why?
|
| Liver Cirrhosis | 1 | 2022 | 78 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2022 | 114 | 0.170 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2020 | 2 | 0.170 |
Why?
|
| Fats | 1 | 2020 | 6 | 0.170 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2020 | 2 | 0.160 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 194 | 0.160 |
Why?
|
| Protein Biosynthesis | 1 | 2020 | 111 | 0.160 |
Why?
|
| RNA-Binding Proteins | 1 | 2020 | 87 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2020 | 472 | 0.160 |
Why?
|
| Cell Line | 3 | 2020 | 700 | 0.150 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2018 | 1 | 0.140 |
Why?
|
| Cholesterol | 2 | 2016 | 203 | 0.140 |
Why?
|
| DNA-Binding Proteins | 2 | 2022 | 490 | 0.140 |
Why?
|
| Aging | 1 | 2025 | 1016 | 0.130 |
Why?
|
| F-Box Proteins | 1 | 2016 | 10 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2020 | 824 | 0.130 |
Why?
|
| Sterol O-Acyltransferase | 1 | 2016 | 1 | 0.130 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 72 | 0.120 |
Why?
|
| Protein Transport | 1 | 2016 | 158 | 0.120 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 1350 | 0.120 |
Why?
|
| Mice | 5 | 2022 | 4802 | 0.120 |
Why?
|
| ErbB Receptors | 1 | 2016 | 100 | 0.120 |
Why?
|
| Hep G2 Cells | 1 | 2015 | 31 | 0.120 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 34 | 0.120 |
Why?
|
| Models, Biological | 1 | 2018 | 469 | 0.120 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 113 | 0.120 |
Why?
|
| RNA Interference | 1 | 2015 | 137 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2015 | 110 | 0.120 |
Why?
|
| Survival Analysis | 1 | 2015 | 288 | 0.110 |
Why?
|
| HEK293 Cells | 1 | 2015 | 202 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2016 | 187 | 0.110 |
Why?
|
| Organogenesis | 1 | 2014 | 12 | 0.110 |
Why?
|
| Cell Membrane | 1 | 2016 | 268 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2014 | 79 | 0.110 |
Why?
|
| Blotting, Western | 1 | 2015 | 515 | 0.110 |
Why?
|
| Stem Cells | 1 | 2014 | 123 | 0.100 |
Why?
|
| Ovarian Neoplasms | 1 | 2020 | 607 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2016 | 163 | 0.100 |
Why?
|
| MicroRNAs | 1 | 2016 | 302 | 0.090 |
Why?
|
| COS Cells | 2 | 2009 | 49 | 0.090 |
Why?
|
| Swine | 2 | 2022 | 238 | 0.090 |
Why?
|
| HeLa Cells | 2 | 2009 | 212 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 482 | 0.090 |
Why?
|
| Female | 5 | 2020 | 15624 | 0.080 |
Why?
|
| Dyneins | 1 | 2009 | 7 | 0.080 |
Why?
|
| Cyclins | 1 | 2009 | 8 | 0.080 |
Why?
|
| raf Kinases | 1 | 2009 | 1 | 0.080 |
Why?
|
| Pseudopodia | 1 | 2009 | 7 | 0.070 |
Why?
|
| Focal Adhesions | 1 | 2009 | 15 | 0.070 |
Why?
|
| NIH 3T3 Cells | 1 | 2009 | 44 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2009 | 57 | 0.070 |
Why?
|
| Muscle Proteins | 1 | 2009 | 56 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 119 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2009 | 68 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2009 | 80 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2009 | 45 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2009 | 267 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 138 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2025 | 427 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2025 | 50 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2025 | 59 | 0.050 |
Why?
|
| Glucagon | 1 | 2022 | 11 | 0.050 |
Why?
|
| Retroperitoneal Space | 1 | 2022 | 9 | 0.050 |
Why?
|
| Transcription Factors, General | 1 | 2022 | 1 | 0.050 |
Why?
|
| Co-Repressor Proteins | 1 | 2022 | 8 | 0.050 |
Why?
|
| Histone Deacetylases | 1 | 2022 | 26 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2022 | 48 | 0.050 |
Why?
|
| Heterografts | 1 | 2022 | 66 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2022 | 25 | 0.050 |
Why?
|
| Adenosine Triphosphatases | 1 | 2022 | 50 | 0.050 |
Why?
|
| Phosphorylation | 2 | 2016 | 585 | 0.050 |
Why?
|
| Multiprotein Complexes | 1 | 2022 | 54 | 0.050 |
Why?
|
| Chromatin | 1 | 2022 | 76 | 0.050 |
Why?
|
| Proteomics | 1 | 2022 | 197 | 0.040 |
Why?
|
| Oncogenes | 1 | 2020 | 34 | 0.040 |
Why?
|
| Adenosine | 1 | 2020 | 33 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 190 | 0.040 |
Why?
|
| Neoplasm Metastasis | 1 | 2020 | 164 | 0.040 |
Why?
|
| Rats | 1 | 2022 | 1588 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2009 | 68 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2020 | 668 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 697 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 1056 | 0.030 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2016 | 5 | 0.030 |
Why?
|
| Threonine | 1 | 2016 | 21 | 0.030 |
Why?
|
| Protein Stability | 1 | 2016 | 43 | 0.030 |
Why?
|
| Feedback | 1 | 2016 | 33 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2016 | 258 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 677 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2016 | 452 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Mesoderm | 1 | 2014 | 16 | 0.030 |
Why?
|
| Glioma | 1 | 2016 | 122 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 344 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2014 | 513 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 634 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2065 | 0.020 |
Why?
|
| Cyclin D3 | 1 | 2009 | 1 | 0.020 |
Why?
|
| Cytoplasmic Dyneins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 10 | 0.020 |
Why?
|
| Myosin Type V | 1 | 2009 | 2 | 0.020 |
Why?
|
| Immobilized Proteins | 1 | 2009 | 9 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 1653 | 0.020 |
Why?
|
| Molecular Mimicry | 1 | 2009 | 30 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 33 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 132 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2009 | 151 | 0.020 |
Why?
|
| Cloning, Molecular | 1 | 2009 | 208 | 0.020 |
Why?
|
| Young Adult | 1 | 2016 | 2833 | 0.020 |
Why?
|
| Adolescent | 1 | 2016 | 3193 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 233 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 5598 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 7414 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 8024 | 0.010 |
Why?
|
| Male | 1 | 2016 | 13921 | 0.010 |
Why?
|